Researchers have found that patients with interstitial lung disease (ILD) are at greatly heightened risk of developing all ...

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a five-year survival rate below 10%.

Machine learning models can help predict which patients receiving systemic therapy for non-small lung cancer are most likely ...

Huntsman Cancer Institute's Discovery Innovations showcase the latest advances in cancer treatment, research, and prevention. These achievements demonstrate the progress being made in ending cancer as ...

Tubulis today announced that its late-breaking abstract covering first clinical data from its ongoing Phase I/IIa NAPISTAR ...

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a five-year survival rate below 10%.

Patent supports AIM’s strategy to expand international market protection, providing opportunities for licensing, ...

For the first time, scientists have identified 27 bacteria and fungi living in our mouths that are implicated in the ...

This article highlights studies that may help inform cancer prevention efforts as well as the treatment of various cancers.

The agreement gives Glenmark exclusive rights to develop and commercialise cancer drug Trastuzumab Rezetecan outside China, ...